RBC Capital Sticks to Its Buy Rating for Zimmer Biomet Holdings (ZBH)
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) yesterday and set a price ...
RBC Capital Keeps Their Hold Rating on BP p.l.c. (BP)
In a report released today, Biraj Borkhataria from RBC Capital maintained a Hold rating on BP p.l.c. (BP – Research Report), with a price ...
RBC Capital lifts Affirm stock price target to $81 from $67
RBC Capital Markets updated its outlook on Affirm Holdings Inc. (NASDAQ:AFRM), raising the company's price target from $67.00 to $81.00 while maintaining a Sector Perform rating on the stock. The ...
RBC lifts Fortinet stock price target to $115 from $97
RBC Capital Markets adjusted its financial outlook on Fortinet (NASDAQ:FTNT) shares, raising the price target to $115 from ...
RBC quantitative analyst makes eight changes to his top 40 stock picks list
RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...
PepsiCo price target lowered to $164 from $172 at RBC Capital
RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...
Biggest of the Big Six: How RBC opened a $100-billion market-cap gap over its banking rivals
J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
Alliance Pharma downgraded by RBC after weak H2, revenue miss
The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.
Hochschild Mining Shares Tumble on 2025 Capital Expenditure, Cost Guidance
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...